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Purpose: The aim of this study is to explore whether a methylation diet inﬂuences risk for adenomatous polyps
(AP) either independently, or interactively with one-carbon metabolism-dependent gene variants, and whether
such a diet modiﬁes blood homocysteine, a biochemical phenotype closely related to the phenomenon of
methylation.
Methods: 249 subjects were examined using selective ﬂuorescence, PCR and food frequency questionnaire
to determine homocysteine, nine methylation-related gene polymorphisms, dietary methionine,
5-methyltetrahydrofolate, vitamins B6 and B12.
Results: 1). Both dietary methionine and 5-methyltetrahydrofolate intake are signiﬁcantly associated with
plasma homocysteine. 2). Dietary methionine is related to AP risk in 2R3R-TS wildtype subjects, while di-
etary B12 is similarly related to this phenotype in individuals heterozygous for C1420T-SHMT, A2756G-
MS and 844ins68-CBS, and in those recessive for 2R3R-TS. 3). Dietary methionine has a marginal inﬂuence
on plasma homocysteine level in C1420T-SHMT heterozygotes, while B6 exhibits the same effect on ho-
mocysteine in C776G-TCN2 homozygote recessive subjects. Natural 5-methyltetrahydrofolate intake is
interesting: Wildtype A1298C-MTHFR, heterozygote C677T-MTHFR, wildtype A2756G-MS and recessive
A66G-MSR individuals all show a signiﬁcant reciprocal association with homocysteine. 4). Stepwise re-
gression of all genotypes to predict risk for AP indicated A2756G-MS and A66G-MSR to be most relevant
(p = 0.0176 and 0.0408 respectively). Results were corrected for age and gender.
Conclusion: Amethylation diet inﬂuences methyl group synthesis in the regulation of blood homocysteine
level, and is modulated by genetic interactions. Methylation-related nutrients also interact with key genes
to modify risk of AP, a precursor of colorectal cancer. Independent of diet, two methylation-related genes
(A2756G-MS and A66G-MSR) were directly associated with AP occurrence.© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Epigenomic methylation controls gene expression, while methyl
groups are also critical for driving neurotransmitter synthesis and
thiol regulation, as well as other important areas of metabolism depen-
dent upon methyl group availability. Clinical phenotypes that may be
affected by alterations in methylation include those related to cancer,
mood disorders and vascular disease [1].
Colorectal cancer (CRC) is the third most common cancer globally,
and the fourth most common cancer-related cause of mortality [2].
Australia has particularly high rates, with CRC being the second most2 4348 4145.
cock).
. This is an open access article undercommonly diagnosed cancer and the third leading cause of cancer-
related deaths [3]. Clinical and histopathological evidence suggests
that most CRC arises from pre-existing benign adenomatous polyps
(APs) [3,4]. CRC and its benign adenoma antecedent are often linked
to nutrition.
Dietary intake of folic acid (especially 5-methyltetrahydrofolate),
vitamins B6, B12 and methionine are particularly important as sources
of, or key factors in methyl group availability. This may be relevant in
tumourgenesis as virtually all CRCs have aberrantly methylated genes
[5]. The dietary supply of the former B-vitamins and methionine is
critical in maintaining one-carbon metabolism [6]. Within one-carbon
transfers, folate, in the form of 5-methyltetrahydrofolate [7] has a
pivotal role in supplying a methyl group to convert homocysteine into
methionine, a vitamin B12 dependent process involving methionine
synthase (MS) and methionine synthase reductase (MSR) (Fig. 1). Thethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.Dietary sources of preformedmethyl groups and associatedmetabolism, including de novo synthesis of methionine. The ﬁgure showswhere nutrients interact as cofactors and the
role of methyl groups in gene expression.
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lism is vitamin B6 dependent serinehydroxymethyl transferase
(SHMT), and the key enzyme directing these one-carbon units to
methyl group metabolism is methylenetetrahydrofolate reductase
(MTHFR) [7].
De novomethionine derived from one-carbon metabolism provides
around half our methionine requirement; diet provides the other half.
Methionine is converted to S-adenosylmethionine, the universalmethyl
donor for methylation of a wide variety of biological substrates [8].
Other enzymes are also crucial to the balance between utilising one-
carbon units for de novo methyl groups or dTMP, which is needed for
DNA synthesis. Ultimately, both of these phenomena are critical
determinants of tumourgenesis.
A shortage of 5-methyltetrahydrofolate or related components of
a healthy ‘methylation diet’ will decrease the biosynthesis of
S-adenosylmethionine, limiting the availability of methyl groups for
methylation reactions. DNA hypomethylation in humans consuming
a low folate diet has been reported in a number of studies [9–11],
and it is reasonable to postulate that an individual's risk of develop-
ing a benign adenoma or subsequent CRC is inﬂuenced by B-vitamin
nutrition. Vegetables, particularly green leafy and cruciferous vege-
tables, are a major source of folate. Studies suggest that both folate
intake and folate status are inversely associated with neoplastic
risk [12]. Common polymorphisms of the genes responsible for
one-carbon metabolism have also been associated with colorectal
neoplasia, providing further evidence for a causal relationship
between folate and neoplasia [13,14].
This study examines whether a methylation diet can inﬂuence risk
for AP either independently or interactively with one-carbon
metabolism-dependent gene variants C677T-MTHFR, A1298C-MTHFR,
A66G-MSR, A2756G-MS, C1420T-SHMT, 2R3R-TS, 1494del6-TS,
C776G-TCN2 and CβS-844ins. The study also examines whether such
a diet can modify the blood homocysteine level, a biochemical pheno-
type closely related to the phenomenon of methylation.2. Materials and methods
Two hundred and forty nine participants (56.2% female 43.8% male)
at Gosford Hospital (NSW) undergoing routine screening for colonic
pathology agreed to participate. Subjects were between 40 and
89 years of age at the time of examination (overall mean age 63.3)
and were mentally competent to complete a food frequency question-
naire (FFQ) interview. Local Human Research Ethics Committee approv-
al was given and informed consent obtained prior to volunteers
participating in the study.
2.1. DNA analysis
Folate gene variants were examined using polymerase chain
reaction (PCR) to amplify blood DNA followed by restriction enzyme di-
gestion and gel electrophoresis; 2R3R-TS (rs34743033) and 1494del6-
TS (rs16430), C1420T-SHMT (rs1979277), C776G-TCN2 (rs1801198),
C677T-MTHFR (rs1801133), A1298C-MTHFR (rs1801131), A2756G-
MS (rs1805087), A66G-MSR (rs10380) and CβS-844ins (no rs) were
analysed according to the following methods respectively: Horie et al.
[15], Ulrich et al. [16], Heil et al. [17], Pietrzyk et al. [18], Van der Put
et al. [19–21], Wilson et al. [22] and Tsai et al. [23]. The term wildtype
assumes ancestral genotype.
2.2. Food Frequency Questionnaire for intake of native
5-methyltetrahydrofolate, vitamins B6, B12, and methionine
Estimated daily intake of nutrients was assessed by interviewer ad-
ministered FFQ. The questionnaire was extensive, covering 225 food
items and all food groups. Subjects were also asked to provide a list of
all supplements they were taking and were asked about these during
the FFQ interview.
The FFQs were analysed using FoodworksTM 2.10.146 (Xyris Soft-
ware, Brisbane, QLD, Australia). This package uses a number of food
Table 1
Descriptive statistics for nutrient intake and blood homocysteine (mean and SEM).
Dietary methionine
(g/day)
Dietary vitamin B6
(mg/day)
Dietary vitamin B12
(μg/day)
Dietary
5-methyltetrahydrofolate
(μg/day)
Plasma
homocysteine
(μmol/L)
All subjects 2.353 0.099 7.218 0.872 20.589 4.280 348.72 9.99 12.747 0.289
AP (n= 57) 2.454 0.202 5.435 0.758 11.748 2.109 356.12 16.96 13.170 0.729
No AP (n= 192) 2.322 0.115 7.749 1.108 23.228 5.511 346.48 11.99 12.687 0.322
109M. Lucock et al. / BBA Clinical 3 (2015) 107–112databases to cover themajority of foods consumed byAustralians. These
include the AusFoods (brands), Aus Nut (base foods) and the New
Zealand—Vitamin and Mineral Supplements 1999 databases. Methods
are as previously described and validated [24–27]. Unlike the other
nutrients assessed here, vitamin B12 data was evaluated by matching
food items from the United States Department of Agricultural (USDA)
National Nutrient Database for Standard References. Analysis differenti-
ated between natural (5-methyltetrahydrofolate) and synthetic
(pteroylmonoglutamate) folate as previously described [25]. It is
reasonable to assume that semi-quantitative FFQs provide a relatively
good overall measure of dietary habits, and reﬂect trends prior to any
diagnosis of colonic pathology. This approach is assumed to better re-
ﬂect longer term dietary habits as compared to other commonly used
methods of dietary assessment such as the 24 hour recall method or
the 7 day food diary. However, clearly this technique is still only a sur-
vey that may be subject to surveying bias and other potential variables.
2.3. Homocysteine assay
A sensitive and selective ﬂuorescence assay was used to measure
plasma homocysteine. Recombinant homocysteine α,γ-lyase produces
hydrogen sulphide (H2S) from homocysteine without interference
from cysteine or other plasma components. The H2S that is produced
is determined following reaction with dibutylphenylenediamine to
form a ﬂourophore that ﬂuoresces at 660 nm (Ex)/710 nm (Em). The
method is as described by Tan et al. [28] and was performed on an
OP-162 homocysteine reader supplied by Jei Daniel (JD) Biotech Corp,
Taipei, Taiwan.
2.4. Statistics
Statistical analysis was performed using JMP (version 11.0; SAS
Institute Inc., Cary, NC, USA). Associations between key variables and re-
lated parameterswere assessed on an a priori basis, and examined using
either standard least squares analysis, or, where nominal/ordinal data
was examined, logistic regression analysis that ﬁts the cumulative re-
sponse probabilities to the logistic distribution function of a linear
model using maximum likelihood; p value (p b 0.05) for the Wald χ2
test/effect likelihood ratio test (use as indicated), provided a signiﬁ-
cance marker for screening effects. Descriptive statistics are presented
as appropriate.
Stepwise regressionwas performed in amixed directionwith signif-
icant probability [0.250] that a parameter be considered as a forward
step and entered into the model or considered as a backward step andTable 2
Relationship between i) nutrient intake and adenomatous polyp occurrence and ii) nutrient i
brackets, slope. Underlined data implies statistically signiﬁcant (i.e. pb0.05).
Dietary methionine
(g/day)
Dietary vitamin B6
(mg/day)
Die
(μg
P r2 (slope) p r2 (slope) p
AP NS – NS – NS
Homocysteine 0.0109 0.113 (0.570) NS – NS
a Not included as part of the model involving nutrient intake and AP risk.removed from the model. Mallow's Cp criterion was used for selecting
the model where Cp ﬁrst approaches p variables.
While an initial p value of 0.05 was set, a Benjamini–Hochberg False
Detection Rate (B-HFDR) correction test was applied to control for mul-
tiple comparisons. Despite this, data is also providedwithout correction,
since an argument exists against using such tests in exploratory data
where potential relationships could be missed [30].
In using the above statistical tests, all values have been corrected for
both age and gender.
3. Results
Table 1 provides descriptive statistics for the dietary intake ofmethi-
onine, vitamins B6, B12 and natural 5-methyltetrahydrofolate. It also
gives data for the plasma homocysteine level. Values show the mean
and standard error of the mean (SEM) for all subjects, subjects who
have had at least one AP and subjects who have never had an AP.
Table 2 shows that the relationship between both dietary methio-
nine intake and plasma homocysteine level, and dietary methylfolate
intake and homocysteine level, is signiﬁcant (p = 0.0109 and 0.0035;
r= 0.113 and 0.113 respectively). The ﬁrst association is positive, and
the second is negative—relationships that are thus consistent with
what might be expected on an a priori basis.
Table 3 examines how methyl group metabolism-related genetic
proﬁles inﬂuence the relationship between nutrient intake and risk of
AP. Dietary methionine is related to AP risk in 2R3R-TS wildtype sub-
jects, while dietary vitamin B12 is similarly related to this phenotype
in individuals heterozygous for C1420T-SHMT, A2756G-MS and
844ins68-CBS, and in those recessive for 2R3R-TS. Table 4 reports how
methyl group metabolism-related genetic proﬁles inﬂuence any
association between nutrient intakes and plasma homocysteine
levels. Dietary methionine has a marginal inﬂuence on the plasma
homocysteine level in C1420T-SHMT heterozygotes, while vitamin
B6 exhibits the same (but signiﬁcant) effect on homocysteine in
C776G-TCN2 homozygote recessive subjects. However, the relation-
ship to 5-methyltetrahydrofolate intake is perhaps most interesting:
The wildtype A1298C-MTHFR and recessive A66G-MSR both showed
a signiﬁcant reciprocal association with homocysteine, and again
this ﬁts with what might be expected, especially given the critical
role of MSR and MTHFR expression products in the de novo pathway
of methionine biosynthesis from homocysteine. Dietary 5-
methyltetrahydrofolate also exhibits a marginal reciprocal effect on
homocysteine in A2756G-MS wildtypes and C677T-MTHFR
heterozygotes.ntake and homocysteine. Values are corrected for age and sex and represent p, r2 and in
tary vitamin B12
/day)
Dietary 5-methyltetrahydro
folate (μg/day)
Plasma
homocysteine
(μmol/L)
r2 (slope) p r2 (slope) p r2 (slope)
– NS – aNS –
– 0.0035 0.113 (−0.007) N/A N/A
Table 3
Methyl group metabolism-related genotypes that exhibit a signiﬁcant association between nutrient intake (methionine, vitamin B6, vitamin B12 and 5-methyltetrahydrofolate) and
adenoma risk. p has been determined using nominal logistic regression followed by an effect likelihood ratio test. Where signiﬁcant, brackets show r2, slope and (in all cases), number
of observations. Italics indicate values approaching signiﬁcance. Results are corrected for age and sex. Where n b 20 statistics was not performed due to the inherent instability. Bold
and underlined data implies statistically signiﬁcant (i.e. pb0.05).
Polymorphism Dietary methionine Dietary vitamin B6
Wildtype Heterozygote Recessive Wildtype Heterozygote Recessive
1494del6-TS NS (116) NS (106) NS (26) NS (116) NS (106) NS (26)
2R3R-TS ⁎0.0139 (0.132,−0.798, 70) NS (122) NS (54) NS (70) NS (122) NS (54)
C1420T-SHMT NS (131) NS (94) NS (23) NS (131) NS (94) NS (23)
C677T-MTHFR NS (117) NS (107) NS (24) NS (117) NS (107) NS (24)
A1298C-MTHFR NS (127) NS (102) NS (19) NS (127) NS (102) NS (19)
A2756G-MS NS (170) NS (71) NS (7) NS (170) NS (71) NS (7)
A66G-MSR NS (51) NS (115) 0.0556 (0.110,−0.865, 82) NS (51) NS (115) NS (82)
844ins68-CBS NS (207) NS (40) N/A NS (207) NS (40) N/A
C776G-TCN2 NS (38) NS (105) NS (58) NS (38) NS (105) NS (58)
Dietary vitamin B12 Dietary 5-methyltetrahydrofolate
Wildtype Heterozygote Recessive Wildtype Heterozygote Recessive
1494del6-TS NS (116) NS (106) NS (26) NS (113) NS (106) NS (26)
2R3R-TS NS (70) NS (122) ⁎0.0295, 0.136, 0.143, 54) 0.0503 (0.102,−0.004, 70) NS (119) NS (54)
C1420T-SHMT NS (131) ⁎0.0147, 0.074, 0.044, 94) NS (23) NS (130) NS (92) NS (23)
C677T-MTHFR NS (117) NS (107) NS (24) NS (117) NS (104) NS (24)
A1298C-MTHFR NS (127) NS (102) NS (19) NS (126) NS (100) NS (19)
A2756G-MS NS (170) ⁎0.0224, 0.114, 0.100, 71 NS (7) NS (168) NS (70) NS (7)
A66G-MSR NS (51) NS (115) NS (82) NS (49) NS (114) NS (82)
844ins68-CBS NS (207 ⁎0.0256 (0.095, 0.132, 40) N/A NS (204) NS (40) N/A
C776G-TCN2 NS (38) NS (105) NS (58) NS (37) NS (104) NS (58)
110 M. Lucock et al. / BBA Clinical 3 (2015) 107–112Stepwise regression analysis of all the genotypeswas used to generate
a model that best predicts the risk for adenoma (n= 247). A2756G-MS
and A66G-MSR provided signiﬁcant p values (p=0.0176 and 0.0408 re-
spectively) with a whole model r2 of 0.0877. When the model contained
all genetic and dietary factors, A66G-MSR remained signiﬁcant (p =
0.0259) with a whole model r2 of 0.0663. These loci are clearly both crit-
ical to the methylation process, and therefore Table 5 shows how the
A2756G-MS and A66G-MSR genotypes and allele distribution varies
with adenoma phenotype.
When a B-HFDR correction was applied for multiple testing, none of
the results in Table 3 withstood the test. However, in Table 4 theTable 4
Methyl group metabolism-related genotypes that exhibit a signiﬁcant association between nut
mocysteine. p has been determined using standard least squares regression followed by an effec
of observations. Italics indicate values approaching signiﬁcance. Results are corrected for age an
underlined data implies statistically signiﬁcant (i.e. pb0.05).
Polymorphism Dietary methionine Dietary vitam
Wildtype Heterozygote Recessive Wildtype
1494del6-TS NS (116) NS (106) NS (25) NS (116)
2R3R-TS NS (70) NS (121) NS (54) NS (70)
C1420T-SHMT NS (130) 0.0587 (0.124, 0.851, 94) NS (23) NS (130)
C677T-MTHFR NS (116) NS (107) NS (24) NS (116)
A1298C-MTHFR NS (127) NS (102) NS (18) NS (127)
A2756G-MS NS (169) NS (71) NS (7) NS (169)
A66G-MSR NS (50) NS (115) NS (82) NS (50)
844ins68-CBS NS (206) NS (40) N/A NS (206)
C776G-TCN2 NS (37) NS (105) NS (58) NS (37)
Dietary vitamin B12 Dietary 5-me
Wildtype Heterozygote Recessive Wildtype
1494del6-TS NS (116) NS (106) NS (25) NS (113)
2R3R-TS NS (70) NS (121) NS (54) NS (70)
C1420T-SHMT NS (130) NS (94) NS (23) NS (129)
C677T-MTHFR NS (116) NS (107) NS (24) NS (116)
A1298C-MTHFR NS (127) NS (102) NS (18) ⁎0.0004 (0.26
A2756G-MS NS (169) NS (71) NS (7) ⁎0.0467 (0.10
A66G-MSR NS (50) NS (115) NS (82) NS (48)
844ins68-CBS NS (206) NS (40) N/A NS (203)
C776G-TCN2 NS (37) NS (105) NS (58) NS (36)relationship for 5-methyltetrahydrofolate remained signiﬁcant follow-
ing B-HFDR, with wildtype A1298C-MTHFR and A2756G-MS having
corrected p values of 0.0036 and 0.0275 respectively.
4. Discussion
Genomic methylation is a critical process in facilitating gene regula-
tion, with mounting evidence suggesting that micronutrients play an
important role inmanyepigenetic phenomena [29], not just the obvious
role that folate, methionine and vitamin B12 in particular play in facili-
tating methyl group transfer, but in wider phenomena such asrient intake (methionine, vitamin B6, vitamin B12 and 5-methyltetrahydrofolate) and ho-
t likelihood ratio test.Where signiﬁcant, brackets show r2, slope and (in all cases), number
d sex. Where n b 20 statistics was not performed due to the inherent instability. Bold and
in B6
Heterozygote Recessive
NS (106) NS (25)
NS(121) NS (54)
NS (94) NS (23)
NS (107) NS (24)
NS (102) NS (18)
NS (71) NS (7)
NS (115) NS (82)
NS (40) N/A
NS (105) ⁎0.0270 (0.239,−0.171, 58)
thyltetrahydrofolate
Heterozygote Recessive
NS (106) NS (25)
NS (118) NS (54)
NS (92) NS (23)
⁎0.0481 (0.196,−0.006, 104) NS (24)
4,−0.0001, 126) NS (100) NS (18)
3,−0.004, 167) NS (70) NS (7)
NS (118) ⁎0.0181 (0.089,−0.009, 82)
NS (40) N/A
NS (104) NS (58)
Table 5
Stepwise regression analysis of all genotypes was used to generate a model that best predicts risk for adenoma (n=247). A2756G-MS and A66G-MSR provided signiﬁcant p values (p=
0.0176 and 0.0408 respectively) with a whole model r2 of 0.0877 (results corrected for age and sex). When the model contained all genetic and dietary factors, A66G-MSR remained sig-
niﬁcant (p= 0.0259 corrected for age and sex). The table therefore provides A2756G-MS and A66G-MSR genotype and allele distribution according to adenoma phenotype.
Polymorphism Adenoma Control
Wildtype Heterozygote Recessive Wildtype Heterozygote Recessive
A2756G-MS 73.7% 19.3% 7% 66.7% 31.8% 1.5%
A66G-MSR 14% 42.1% 43.9% 22.4% 47.4% 30.2%
Adenoma Control
Wildtype allele Recessive allele Wildtype allele Recessive allele
A2756G-MS 83.3% 16.7% 71.2% 28.8%
A66G-MSR 35.1% 64.9% 46.1% 53.9%
111M. Lucock et al. / BBA Clinical 3 (2015) 107–112microRNA occurrence/function [29]. The link between relevant aspects
of one-carbon metabolism and colon pathoaetiology is compelling,
and the present data provide valuable new information linking diet to
the development of AP.
Findings strongly suggest that a diet that promotes foods rich in
components needed as methyl group donors, can inﬂuence risk for AP,
but not independently. The associations are largely interactive, with
methionine linked to 2R3R-TS genotype and vitamin B12 linked to
2R3R-TS, C1420T-SHMT, A2756G-MS and 844ins68-CBS genotypes.
The expression products of these genes are notable in that they
introduce one-carbon units into one-carbon metabolism (SHMT) and
regulate the balance between homocysteine remethylation and
transsulphuration (MS and CBS). Thymidylate synthase is the key en-
zyme in DNA-dTMP synthesis, and is therefore likely to be relevant in
the pathoaetiology of colonic neoplasms. Dietary factors were also
linked to homocysteine levels via gene interaction, and of particular
note is the role of natural food 5-methyltetrahydrofolate in lowering
this thiol in an A1298C-MTHFR, C677T-MTHFR, A2756G-MS and
A66G-MSR dependent fashion. When the B-HFDR correction is applied
for multiple testing, the wildtype A1298C-MTHFR and A2756G-MS re-
main signiﬁcant factors (p = 0.0036 and 0.0275 respectively). This is
perhaps not too surprising, nor is a potential role for C1420T-SHMT in
determining a relationship between dietary methionine and homocys-
teine (relationship approaches signiﬁcance); provision of one-carbon
units by SHMT will need to be regulated by methionine intake. Howev-
er, it's more difﬁcult to explain why dietary vitamin B6 should interact
with TCN2 genotype to modify homocysteine, although this might
stem from an overlap with vitamin B12 status in the regulation of the
balance between homocysteine remethylation (B12 dependent) and
transsulphuration (B6 dependent), especially given that the TCN2
expression product is important in B12 transport and metabolism.
While a diet rich in components needed as methyl group donors did
not independently inﬂuence risk for AP, two of the components exam-
ined (methionine and 5-methyltetrahydrofolate) did independently in-
ﬂuence homocysteine. This is particularly interesting as a stepwise
regression model that took account of all the polymorphisms examined
found that only A2756G-MS and A66G-MSR had a signiﬁcant inﬂuence
on the occurrence of the adenoma phenotype. MS and MSR are the key
enzyme proteins that convert homocysteine into methionine in a
5-methyltetrahydrofolate dependent reaction central to de novomethyl
group synthesis. When a model that contained both all genetic and die-
tary factors was used, only A66G-MSR remained signiﬁcant (p =
0.0259). As with the previous data, values were corrected for age and
gender.
Van den Veyer has suggested that an optimal “methylation diet”
should be investigated aspart of theprevention and treatment of bothde-
velopmental and adult onset disorders citing relevant conditions such as
cancers, neural tube defects and Rett syndrome [31]. Certainly genomic
methylation, as an epigenetic phenomenon, has been implicated as a
mechanism in which maternal nutrition modiﬁes offspring phenotype
in both agouti mouse and honeybee models. These DNA methylation-related phenotypic changes have been linked to folate metabolism, and
it is believed that organ-speciﬁc DNA methylation patterns are
established during the foetal period via epigenetic reprogramming. This
is not necessarilyﬁxed and can bemodulated over the course of a lifespan
by environmental inﬂuences [32]. There is little doubt that the exposome,
particularly dietary exposure, plays a major role in developmental pro-
cesses, contributing to the developmental origins hypothesis of adult dis-
ease. Later in life, aberrant methylation status and dietary factors related
to methylation potential have again been linked to cancers with virtually
all CRCs having aberrantly methylated genes [5]. The relevance goes be-
yond this, with aberrant methylation underpinning aspects of the ageing
process per se [32]. While the greatest attention has been on folate in re-
spect of epigenetic processes, it seems likely that vitamins B2, B6, B12 and
preformed methionine are also potentially important. The present study
seems to highlight dietary vitamin B12 and natural 5-
methyltetrahydrofolate as being particularly relevant when key variant
genes related to methylation are taken into account (Tables 3 and 4).
5. Conclusion
In conclusion, this study implicates dietary nutrients essential for
methyl group synthesis in the regulation of blood homocysteine level,
and suggests that genetic interactions contribute to this relationship. A
methylation diet also seems to interact with key genes to modify the
risk of AP, a clinical phenotype linked to the development of CRC. Inde-
pendent of diet, twomethylation-related genes were also directly asso-
ciated with AP occurrence.
Transparency document
The Transparency document associated with this article can be
found, in the online version.
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